Related Experiment Video

Updated: Mar 11, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.5K

Statin Use and Recurrent Atherosclerotic Cardiovascular Disease Events in Patients With Coronary Artery Intervention:

Omair Ahmed1, Jianhui Zhu2, Floyd Thoma2

  • 1Division of Geriatrics, Warren Alpert School of Medicine Brown University Providence RI USA.

Journal of the American Heart Association
|March 10, 2026
PubMed

Insights

Guideline-directed statin intensity (GDSI) significantly reduces recurrent atherosclerotic cardiovascular disease (ASCVD) events and mortality in patients after revascularization compared to less intensive statin therapy or no statins. Optimizing statin use improves cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Atherosclerotic cardiovascular disease (ASCVD) is a major global health concern.
  • Statins are effective in lowering LDL cholesterol and cardiovascular risk.
  • Patients with coronary artery disease undergoing revascularization remain at high risk for recurrent ASCVD events.

Purpose of the Study:

  • To investigate the association between statin intensity, LDL cholesterol levels, and recurrent ASCVD events in patients after coronary interventions.
  • To evaluate the effectiveness of guideline-directed statin intensity (GDSI) versus less intensive regimens or no statin therapy.

Main Methods:

  • Retrospective analysis of 45,949 patients aged ≥18 who underwent revascularization (CABG or PCI) since 2010.
  • Patients were stratified by statin intensity: GDSI,
  • Outcomes included myocardial infarction, ischemic stroke, and all-cause mortality over a median 6-year follow-up.

Main Results:

  • Patients on GDSI (65%) had significantly lower rates of myocardial infarction, myocardial infarction/revascularization, and ischemic stroke/transient ischemic attack compared to
  • LDL cholesterol levels ≤70 mg/dL were associated with fewer adverse events.
  • Multivariable analysis confirmed that GDSI significantly reduced recurrent ASCVD events and mortality.

Conclusions:

  • Guideline-directed statin intensity (GDSI) is more effective in reducing recurrent ASCVD events and mortality than less intensive statin regimens or no statins.
  • Optimizing statin therapy and monitoring LDL cholesterol levels are crucial for improving ASCVD management and patient outcomes.
Abstract

Keywords:
ASCVDcoronary artery interventionmortalitystatin

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
790
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
372